IRIS
BONIFACINO, TIZIANA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 14.557
AS - Asia 2.406
NA - Nord America 1.583
SA - Sud America 191
AF - Africa 41
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 1
Totale 18.786
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 14.165
US - Stati Uniti d'America 1.486
SG - Singapore 991
CN - Cina 669
VN - Vietnam 458
FR - Francia 126
BR - Brasile 116
FI - Finlandia 75
HK - Hong Kong 75
BD - Bangladesh 56
GB - Regno Unito 44
AR - Argentina 40
MX - Messico 36
DE - Germania 35
CA - Canada 34
JP - Giappone 28
ID - Indonesia 23
IQ - Iraq 17
CH - Svizzera 14
ZA - Sudafrica 14
IN - India 13
PL - Polonia 12
UA - Ucraina 12
RU - Federazione Russa 11
IE - Irlanda 10
SA - Arabia Saudita 10
ES - Italia 9
JM - Giamaica 9
NL - Olanda 9
PH - Filippine 8
TW - Taiwan 8
AE - Emirati Arabi Uniti 7
DZ - Algeria 7
PK - Pakistan 7
AU - Australia 6
CL - Cile 6
CO - Colombia 6
EC - Ecuador 6
MY - Malesia 6
PY - Paraguay 6
SI - Slovenia 6
VE - Venezuela 6
SE - Svezia 5
CR - Costa Rica 4
LT - Lituania 4
TR - Turchia 4
AT - Austria 3
BO - Bolivia 3
HN - Honduras 3
JO - Giordania 3
KR - Corea 3
NP - Nepal 3
RO - Romania 3
SN - Senegal 3
TT - Trinidad e Tobago 3
AL - Albania 2
AO - Angola 2
BS - Bahamas 2
EG - Egitto 2
GR - Grecia 2
IL - Israele 2
KE - Kenya 2
KZ - Kazakistan 2
LY - Libia 2
MA - Marocco 2
MD - Moldavia 2
MT - Malta 2
NI - Nicaragua 2
OM - Oman 2
PT - Portogallo 2
SV - El Salvador 2
TH - Thailandia 2
TN - Tunisia 2
UY - Uruguay 2
AZ - Azerbaigian 1
BB - Barbados 1
BE - Belgio 1
BH - Bahrain 1
CI - Costa d'Avorio 1
CY - Cipro 1
DJ - Gibuti 1
DK - Danimarca 1
ET - Etiopia 1
GE - Georgia 1
KW - Kuwait 1
NC - Nuova Caledonia 1
PA - Panama 1
QA - Qatar 1
RS - Serbia 1
SD - Sudan 1
SK - Slovacchia (Repubblica Slovacca) 1
SY - Repubblica araba siriana 1
TL - Timor Orientale 1
UZ - Uzbekistan 1
XK - ???statistics.table.value.countryCode.XK??? 1
YT - Mayotte 1
Totale 18.786
Salva come PNG Salva come JPEG
Città #
Genova 6.178
Genoa 5.298
Vado Ligure 1.295
Rapallo 1.170
San Jose 511
Singapore 506
Ashburn 178
Ho Chi Minh City 149
Lauterbourg 111
Beijing 105
Hanoi 105
Council Bluffs 91
New York 79
Helsinki 74
Hong Kong 72
Bordighera 34
Los Angeles 33
Santa Clara 30
Frankfurt am Main 27
Orem 25
Tokyo 23
Rome 22
Da Nang 21
Milan 21
São Paulo 21
Haiphong 20
Montreal 18
Mexico City 16
Atlanta 15
Basingstoke 14
Zurich 14
Kyiv 12
Baghdad 11
Chicago 11
St Louis 11
Tianjin 11
Dublin 10
Buffalo 9
Can Tho 9
Phoenix 9
Piscataway 9
Turin 9
Boardman 8
Denver 8
Hải Dương 8
Johannesburg 8
Naples 8
Dallas 7
Kingston 7
Quảng Ngãi 7
Staten Island 7
Amsterdam 6
Biên Hòa 6
Brooklyn 6
Buenos Aires 6
Denton 6
Houston 6
Ljubljana 6
Madrid 6
Messina 6
Paris 6
Phủ Lý 6
Warsaw 6
Bari 5
Charlotte 5
Hamden 5
Jeddah 5
London 5
Thái Bình 5
Birmingham 4
Bắc Ninh 4
Bến Tre 4
Columbus 4
Curitiba 4
Jakarta 4
Krakow 4
Marseille 4
Nha Trang 4
Padua 4
Poplar 4
Shijiazhuang 4
Sydney 4
Tampa 4
Toronto 4
Tân Tiến 4
Wuhan 4
Zhengzhou 4
Amman 3
Bologna 3
Bình Phước 3
Castellana Grotte 3
Changsha 3
Chongqing 3
Cincinnati 3
Cisano Bergamasco 3
City of London 3
Dakar 3
Dubai 3
Guayaquil 3
Hangzhou 3
Totale 16.668
Salva come PNG Salva come JPEG
Nome #
Genetic inactivation of mGlu5 receptor improves motor coordination in the Grm1crv4 mouse model of SCAR13 ataxia 238
Characterization of the Mitochondrial Aerobic Metabolism in the Pre- and Perisynaptic Districts of the SOD1G93A Mouse Model of Amyotrophic Lateral Sclerosis 238
Acute stress increases depolarization-evoked glutamate release and presynaptic SNARE complex accumulation in prefrontal/frontal cortex. The dampening action of antidepressants. 236
In-vivo effects of knocking-down metabotropic glutamate receptor 5 in the SOD1G93A mouse model of amyotrophic lateral sclerosis. 231
In-vivo genetic ablation of metabotropic glutamate receptor type 5 slows down disease progression in the SOD1G93A mouse model of amyotrophic lateral sclerosis 227
Altered mechanisms underlying the abnormal glutamate release in amyotrophic lateral sclerosis at a pre-symptomatic stage of the disease 209
Blockade of stress-induced increase of glutamate release in the rat prefrontal/frontal cortex by agomelatine involves synergy between melatonergic and 5-HT2C receptor-dependent pathways 205
Altered Mechanisms Underlying the Abnormal Glutamate Release in Amyotrophic Lateral Sclerosis at a Pre-Symptomatic Stage of the Disease. 203
Chronic mild stress induces anhedonic behavior and changes in glutamate release, BDNF trafficking and dendrite morphology only in stress vulnerable rats. The rapid restorative action of ketamine 197
Altered glucose catabolism in the presynaptic and perisynaptic compartments of SOD1G93A mouse spinal cord and motor cortex indicates that mitochondria are the site of bioenergetic imbalance in ALS 193
Exocytosis regulates trafficking of GABA and glycine heterotransporters in spinal cord glutamatergic synapses: a mechanism for the excessive heterotransporter-induced release of glutamate in experimental amyotrophic lateral sclerosis. 192
The endocannabinoid system in rat gliosomes and its role in the modulation of glutamate release 184
Enhanced Function and Overexpression of Metabotropic Glutamate Receptors 1 and 5 in the Spinal Cord of the SOD1G93A Mouse Model of Amyotrophic Lateral Sclerosis during Disease Progression 183
Abnormal exocytotic release of glutamate in a mouse model of amyotrophic lateral sclerosis 179
Acute stress rapidly increases the readily releasable pool of glutamate vesicles in prefrontal and frontal cortex through non-genomic action of corticosterone 174
Colocalization of neurotransmitter transporters on the plasma membrane of the same nerve terminal may reflect cotransmission. 173
Knocking down metabotropic glutamate receptor 1 improves survival and disease progression in the SOD1G93A mouse model of amyotrophic lateral sclerosis 171
Enriched experience and recovery from amblyopia in adult rats: impact of motor, social and sensory components. 170
Group I metabotropic glutamate autoreceptors induce abnormal glutamate exocytosis in a mouse model of amyotrophic lateral sclerosis 166
Abnormal exocytotic release of glutamate in a mouse model of amyotrophic lateral sclerosis. 166
Metabotropic glutamate receptor 5 as a potential target in ALS 164
Excessive and precocious glutamate release in the spinal cord of a mouse model of amyotrophic lateral sclerosis 159
Chronic treatment with agomelatine or venlafaxine reduces depolarization-evoked glutamate release from hippocampal synaptosomes 158
Intravenous Mesenchymal Stem Cells Improve Survival and Motor Function in Experimental Amyotrophic Lateral Sclerosis 158
Abnormal and precocious exocytotic glutamate release in a mouse model of amyotrophic lateral sclerosis 157
Amyotrophic lateral sclerosis and excitotoxicity: role of Group I metabotropic glutamate receptors 156
Acute Ketamine Facilitates Fear Memory Extinction in a Rat Model of PTSD Along With Restoring Glutamatergic Alterations and Dendritic Atrophy in the Prefrontal Cortex 155
Differential expression of metabotropic glutamate and GABA receptors at neocortical glutamatergic and GABAergic axon terminals 154
Glutamate release from astrocytic gliosomes under physiological and pathological conditions 153
Abnormal Upregulation of GPR17 Receptor Contributes to Oligodendrocyte Dysfunction in SOD1 G93A Mice 152
The complex phenotype and function of spinal cord microglia during ALS progression and the impact of metabotropic glutamate receptor type 5 down-regulation in SOD1G93A mice 151
Altered Mechanisms Underlying the Abnormal Glutamate Release in Amyotrophic Lateral Sclerosisat a Pre-Symptomatic Stage of the Disease. 150
mGluR1 and mGluR5 knock-down improves survival, motor skills and disease progression in amyotrophic lateral sclerosis mouse model 145
Astrocyte contribution to the excessive glutamate release in the spinal cord of the SOD1G93A mouse model of amyotrophic lateral sclerosis 145
Effect of miRNAs shuttled by exosomes derived from primed-MSCs on activated-microglia phenotype and possible implication in amyotrophic lateral sclerosis. 145
Fluoxetine in adulthood normalizes GABA release and rescues hippocampal synaptic plasticity and spatial memory in a mouse model of Down Syndrome. 144
Abnormal glutamate release in a mouse model of amyotrophic lateral sclerosis 144
Targeting Group I Metabotropic Glutamate Receptors in Amyotrophic Lateral Sclerosis 142
Abnormal glutamate release in a mouse model of amyotrophic lateral sclerosis 142
Role of calpain-1 in the early phase of experimental ALS 142
Genetic and pharmacological effects of mGlu5 receptor blockade in the SOD1G93A mouse model of amyotrophic lateral sclerosis 141
Group I metabotropic glutamate receptors tune excitotoxicity in amyotrophic lateral sclerosis 140
Abnormal glutamate release induced by group I metabotropic glutamate receptors in experimental ALS. 140
In vitro Evidence of Abnormal Glutamate to Glutamine Conversion in Astrocytes harvested from a Mouse Model of Amyotrophic Lateral Sclerosis: a potential Experimental Application of N-13-ammonia 140
Acute stress and corticosterone increase the readily releasable pool of glutamatergic vesicles in rat synaptosomes of prefrontal/frontal cortex via mineralocorticoid and glucocorticoid receptors 139
Acute stress rapidly increases the readily releasable pool of glutamate vesicles in prefrontal and frontal cortex through non-genomic action of corticosterone. 138
Changes at glutamate tripartite synapses in the prefrontal cortex of a new animal model of resilience/vulnerability to acute stress 137
Acute ketamine restores deficits in glutamate release and related molecular mechanisms induced by chronic mild stress in vulnerable rats 136
GroupI metabotropic glutamate autoreceptors induce abnormal glutamate exocytosis in a mouse model of amyotrophic lateral sclerosis 135
Intravenous mesenchymal stem cells administration induces survival and symptom amelioration in mutant SOD1 G93A mice 135
In-vivo therapeutic effects of extracellular vesicles derived from mesenchymal stem after systemic administration on ALS mice 134
GROUP I METABOTROPIC GLUTAMATE RECEPTORS AND NEUROTOXICITY IN AMYOTROPHIC LATERAL SCLEROSIS 134
Alterations of Synaptic Mechanisms and Excessive Glutamate Release in the Spinal Cord of SOD1G93A Mice 133
A multistationary loop model of ALS unveils critical molecular interactions involving mitochondria and glucose metabolism 133
Altered synaptic mechanisms and excessive glutamate release in amyotrophic lateral sclerosis 131
miRNAs shuttled by exosomes derived from primed-MSCs affect the activated-microglia phenotype and possibly support the therapeutic effects of MSC administration in SOD1G93A mice 130
Synaptic mechanisms underlying the excessive and precocious glutamate release in the spinal cord of sod1g93a mice. 129
Alterations of Synaptic Mechanisms and Excessive Glutamate Release in the Spinal Cord of SOD1G93A Mice 129
Blocking glutamate mGlu5 receptors with the negative allosteric modulator CTEP improves disease course in SOD1G93A mouse model of amyotrophic lateral sclerosis 129
Genetic inactivation of metabotropic glutamate 5 (mGlu5) receptor ameliorates motor coordination in the Grm1crv4 mouse model of SCAR13 ataxia 128
Molecular mechanisms supporting abnormal glutamate release in the spinal cord of a mouse model of Amyotrophic Lateral Sclerosis. 127
Intravenous mesenchymal stem cells administration induces survival and symptom amelioration in mutant SOD1 G93A mice 127
Knocking-down mGlu1 receptors prolongs survival and ameliorates disease progression in the SOD1/G93A mouse model of ALS. 126
Stress and corticosterone increase the readily releasable pool of glutamate vesicles in synaptic terminals of prefrontal and frontal cortex 126
Targeting group i metabotropic glutamate receptors in experimental als. 126
Group I metabotropic glutamate receptors in ALS: knocking-down mGlu1 receptors ameliorates survival and disease progression in SOD1/G93A mice. 125
Knocking-down mGluR1 and mGluR5 in the SOD1/G93A mouse model of amyotrophic lateral sclerosis ameliorates survival and disease progression 125
The Modulation of Glutamate Release by Group I Metabotropic Glutamate Auto-Receptors in ALS 123
Increased [3H]D-aspartate release and changes in glutamate receptor expression in the hippocampus of the mnd mouse. 123
Group I metabotropic glutamate receptors modulate glutamate exocytosis in a mouse model of als 123
Mechanisms underlying the predictive power of high skeletal muscle uptake of FDG in amyotrophic lateral sclerosis 123
Non conventional activity of the endocannabinoid system at glutamate release in rat cortical astrocytes 122
Group I metabotropic glutamate receptors induce excessive glutamate release in the spinal cord of sod1g93a mice 122
In-vitro and in-vivo studies depict metabotropic glutamate receptor 5 as a potential pharmacological target to modulate disease progression in ALS 122
The modulation of Glutamate release by Group I metabotropic Glutamate auto-receptors in ALS 121
Genetic and pharmacological effects by blocking mGlu5 Receptor in the SOD1G93A Mouse Model of Amyotrophic Lateral Sclerosis 121
In-vitro activation of GAT1 transporters expressed in spinal cord gliosomes stimulates glutamate release that is abnormally elevated in the SOd1/G93A(+) mouse model of amyotrophioc lateral sclerosis. 120
Knocking down mglu1 receptors prolongs survival and improves symptomatology in a mouse model of amyotrophic lateral sclerosis 119
GLUTAMATE NEUROTRANSMISSION IS MODIFIED IN THE SOD1/G93A MOUSE MODEL OF ALS 118
Ketamine modulates glutamate release, BDNF trafficking and dendrite morphology in rats vulnerable to chronic mild stress 118
Acute stress rapidly increases the readily releasable pool of glutamate vesicles in prefrontal and frontal cortex through corticosterone non-genomic action 117
Knocking-down mGluR1 and mGluR5 in SOD1G93A mice ameliorates survival and disease progression 117
Mesemchymal stem cells systemically administered in symptomatic mutant SOD1-G93A mice ameliorate survival and motor abilities 116
Inactivation of the Grm5 gene improves motor coordination defects in the Grm1crv4 mouse model of SCAR13 ataxia 116
Synaptic Mechanisms Sustaining The Excessive And Precocious Glutamate Release In The Spinal Cord Of SOD1G93A Mice 116
Fluoxetine treatment promotes functional recovery in a rat model of cervical spinal cord injury 115
Knocking-down Group I metabotropic glutamate receptors ameliorates survival and disease progression in SOD1G93A mice. 115
Altered expression of the GPR17 receptor in the spinal cord of SOD1G93A mice, a model of amyotrophic lateral sclerosis 115
null 114
Genetic Downregulation of the Metabotropic Glutamate Receptor Type 5 Dampens the Reactive and Neurotoxic Phenotype of Adult ALS Astrocytes 113
Acute stress increases the readily releasable pool of glutamate vesicles in cortical areas 113
Reducing the expression of mGlu1 and mGlu5 receptors ameliorates survival and disease progression in SOD1G93A mice 112
In-vivo and in-vitro evidence supporting the role of mGlu5 receptor as a key regulator of glutamate downstream effects in ALS 111
MicroRNA Alteration, Application as Biomarkers, and Therapeutic Approaches in Neurodegenerative Diseases 111
Excessive glutamate release and undelying synaptic mechanisms in a mouse model of amyotrophic lateral sclerosis 110
mGlu5 receptor negative allosteric modulation reduces the aberrant cellular reactivity and neurotoxicity of reactive human astrocytes differentiated from fibroblast of SOD1 and C9orf72 ALS patients 110
Preclinical study showing a gender specific protective properties of conjugated linoleic acid (CLA) for amyotrophic lateral sclerosis 109
Group I metabotropic glutamate receptors in ALS: mGluR1 and mGluR5 autoreceptors induce excessive glutamate release in SOD1/G93A mice. 109
Abnormal and precocious exocytotic release of glutamate in the spinal cord of a mouse model of amyotrophic lateral sclerosis. 108
Genetic and pharmacological effects by blocking mGlu5 receptor in the SOD1G93A mouse model of amyotrophic lateral sclerosis 107
Totale 14.353
Salva come PNG Salva come JPEG
Categoria #
all - tutte 60.399
article - articoli 25.726
book - libri 533
conference - conferenze 34.140
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 120.798
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202170 0 0 0 0 0 0 0 0 0 0 0 70
2021/20221.332 21 85 62 127 50 107 83 322 84 126 68 197
2022/20231.440 137 147 21 164 212 201 15 104 214 12 183 30
2023/20241.113 36 124 33 135 80 235 95 43 46 61 74 151
2024/20253.571 189 237 82 240 388 325 302 664 103 159 408 474
2025/20266.598 822 173 435 497 1.070 433 959 382 569 728 362 168
Totale 19.339